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Background  
Pseudomonas aeruginosa is the major responsible for the high mortality rate of cystic fibrosis (CF) patients due to the 
development of chronic infections. To long persist, P. aeruginosa uses sophisticated mechanisms to achieve full-
adaptation, mainly triggered by the harsh environmental conditions of CF lungs. The influence of Staphylococcus aureus, a 
primary colonizer of CF lungs, in increasing P. aeruginosa pathogenicity has also been reported. The main objective of this 
study was to decipher the impact of S. aureus on P. aeruginosa pathogenicity using in vitro conditions mimicking CF lungs. 
 
Method  
Antibiotic sensitive and resistant strains of S. aureus and P. aeruginosa were grown in artificial CF sputum medium and 
cultured at different timings to simulate a typical colonization of patient lungs. S. aureus was first cultured for 3 days, and 
then P. aeruginosa was co-cultured for another 4 days. In the last 4 days the co-cultures were exposed to aggressive 
ciprofloxacin treatment. Samples were collected every 24 h to analyze bacterial growth kinetics and phenotypic diversity.  
 
Results & Conclusions  
Results showed that growth kinetics of P. aeruginosa and its phenotypic diversity was not affected by the presence of S. 
aureus. Interestingly, the presence of S. aureus seemed to inhibit the emergence of P. aeruginosa small colony variants 
(SCV) that have emerged when the resistant strain was cultured alone. Likewise, S. aureus seemed not provide any 
resistant advantage to P. aeruginosa when facing ciprofloxacin treatments. These results do not substantiate the role of S. 
aureus on P. aeruginosa persistence pointed out by some studies that reported S. aureus extracellular factors increased P. 
aeruginosa growth activity and resistance towards antibiotics by inducing the emergence of SCV. Discrepancies may be 
explained by the different in vitro conditions used. The majority of the studies used standard laboratory medium that does 
not fully mimic the chemical and nutritional complex environment found in CF lungs. Furthermore, this study mimics a 
typical lung colonization timeline. In effect, S. aureus was cultured prior to P. aeruginosa, as happen in vivo, to allow its 
adaptation to CF environment. P. aeruginosa co-cultured with CF-adapted S. aureus may produce these different, but 
more reliable, outcomes. In conclusion, the development of P. aeruginosa chronic infections seems not to be driven by S. 
aureus. 
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